| Name | Bryodulcosigenin |
| Description | Bryodulcosigenin has anti-inflammatory effect, it shows potent inhibitory effects on EBV-EA induction. |
| In vitro | The structures of 1-7 were determined on the basis of spectroscopic and chemical methods. Six compounds, 2, 3, 5, and 7-9, and 11 compounds, 1-9, Bryodulcosigenin (10), and bryosigenin (11), respectively, were evaluated for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation (1 microg/ear) in mice and on Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 65 mg/mL (136.92 mM), Sonication is recommended.
|
| Keywords | Inhibitor | inhibit | Inflammationrelated | Inflammation related | Immunologyrelated | Immunology/Inflammation related | Immunology related | Immunology & Inflammation related | Bryodulcosigenin |
| Inhibitors Related | Benzyl cinnamate | (9α,13α,14α)-4-Hydroxy-3,7-dimethoxy-7,8-didehydromorphinan-6-one | Pirazolac | Sodium Iodoacetate | Teneligliptin hydrobromide | Soquelitinib | Difenpiramide | Anti-inflammatory agent 36 | Piperacetazine | MG-T-19 | Anti-inflammatory agent 35 | Complete Freund's adjuvant |
| Related Compound Libraries | Terpene Natural Product Library | Bioactive Compound Library | Traditional Chinese Medicine Monomer Library | Selected Plant-Sourced Compound Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Natural Product Library | Saccharide and Glycoside Natural Product Library | Inhibitor Library | Natural Product Library for HTS | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max |